Singapore markets open in 3 hours 27 minutes

INMD Jan 2023 80.000 put

OPR - OPR Delayed Price. Currency in USD
Add to watchlist
56.800.00 (0.00%)
As of 11:58AM EDT. Market open.
Full screen
Previous close56.80
Open56.80
Bid55.50
Ask60.00
Strike80.00
Expiry date2023-01-20
Day's range56.80 - 56.80
Contract rangeN/A
Volume1
Open interest31
  • Motley Fool

    3 Highly Profitable Stocks That Are Super Cheap Right Now

    Bear markets are never fun. Keeping with this theme, the 2022 bear market has created a slew of attractive buying opportunities. Cosmetic surgery company InMode (NASDAQ: INMD),  Swiss pharma giant Novartis (NYSE: NVS), and diabetes care behemoth DexCom (NASDAQ: DXCM) are three highly profitable companies that have been unfairly punished by this irrational market.

  • Motley Fool

    Which Growth Stock Is a Better Buy Right Now -- AbbVie or InMode?

    The popularity of cosmetic procedures is unquestionably on the rise. Major pharmaceutical AbbVie (NYSE: ABBV) is plagued by concerns about the impending patent cliff on its top-selling drug. At the same time, healthcare equipment provider InMode (NASDAQ: INMD) has been punished by Wall Street's current skepticism about growth stocks.

  • Motley Fool

    This Beaten-Down Growth Stock Has Significant Upside Potential. Time to Buy?

    Shareholders of medical technology company InMode (NASDAQ: INMD) have not had a great 2022; the stock has fallen roughly 50% since the beginning of the year. Here are three reasons to consider InMode as a long-term growth stock for your portfolio. InMode designs and builds non-invasive medical equipment for cosmetic procedures like face and body contouring, hair removal, and women's wellness.